Cleo Diagnostics Ltd (COV) — Net Asset Momentum

Latest YoY growth as of June 2025: -37.9%

Cleo Diagnostics Ltd (COV) recorded a net asset momentum of -37.9% as of June 2025, with net assets of AU$5.83 Million AUD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See net assets of Cleo Diagnostics Ltd for net asset value and shareholders' equity analysis.

YoY Momentum

-37.9%
Year-over-year

Current Net Assets

AU$5.83 Million
AUD · June 2025

Years of Data

4
2022 – 2025

Country

Australia
AU

Cleo Diagnostics Ltd Net Asset Momentum (2022–2025)

This chart tracks Cleo Diagnostics Ltd's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -37.9%, with net assets of AU$5.83 Million AUD as of June 2025. For live market cap and overall valuation, see Cleo Diagnostics Ltd market cap and net worth.

Annual Net Asset History for Cleo Diagnostics Ltd (2022–2025)

The table below shows the complete annual net asset history for Cleo Diagnostics Ltd from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Cleo Diagnostics Ltd to evaluate the tangible quality of the company's equity base.

Year Net Assets (AUD) Total Assets Total Liabilities YoY Momentum
2025 AU$5.83 Million AU$6.94 Million AU$1.10 Million ▼ -37.9%
2024 AU$9.39 Million AU$9.88 Million AU$486.22K ▲ +1095.5%
2023 AU$-943.41K AU$1.08 Million AU$2.02 Million ▼ -2131.3%
2022 AU$-42.28K AU$243.61K AU$285.89K